Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Physical Chemistry Chemical Physics : PCCP|October 7, 2016
Observation of nanotwinning and room temperature ferromagnetism in sub-5 nm BiFeO<sub>3</sub> nanoparticles: a combined experimental and theoretical studyMandar M Shirolkar, Xiaolei Dong, Jieni Li, et al.Nanomaterials (Basel, Switzerland)|May 26, 2019
CuO/ZnO Heterojunction Nanorod Arrays Prepared by Photochemical Method with Improved UV Detecting PerformanceJieni Li, Tingting Zhao, Mandar M Shirolkar, et al.Applied Microbiology and Biotechnology|June 15, 2014
Formation of filamentous aerobic granules: role of pH and mechanismChunli Wan, Xue Yang, Duu-Jong Lee, et al.Journal of Managed Care & Specialty Pharmacy|September 4, 2020
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective AnalysisQing Huang, Sujana Borra, Jieni Li, et al.Multiple Sclerosis and Related Disorders|April 4, 2024
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosisJagadeswara Rao Earla, Jieni Li, George J Hutton, et al.Multiple Sclerosis and Related Disorders|March 12, 2022
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSISJieni Li, Soumya G Chikermane, Jagadeswara R Earla, et al.Pharmacotherapy|May 9, 2023
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosisJagadeswara Rao Earla, Jieni Li, George J Hutton, et al.BMC Medical Research Methodology|October 29, 2025
Comparison of machine learning methods versus traditional Cox regression for survival prediction in cancer using real-world data: a systematic literature review and meta-analysisYinan Huang, Shadi Bazzazzadehgan, Jieni Li, et al.Preventive Medicine|November 18, 2024
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United StatesJieni Li, George J Hutton, Tyler J Varisco, et al.Clinical Pharmacology and Therapeutics|November 15, 2024
Infection Risk Associated with High-Efficacy Disease-Modifying Agents in Multiple Sclerosis: A Retrospective Cohort StudyJieni Li, George J Hutton, Tyler J Varisco, et al.Pageof 5